11C-methionine in Diagnostics and Management of Glioblastoma Multiforme Patients (GlioMET)
Clinical trial NCT05608395 · COMPLETED
Trial details
- NCT number
- NCT05608395
- Sponsor
- Masaryk Memorial Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-04
- Primary completion
- 2024-06-20
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.